go 6976 has been researched along with axitinib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giranda, VL; Johnson, EF; Luo, Y; Stewart, KD; Woods, KW | 1 |
Awrey, DE; Ban, F; Beletskaya, I; Edwards, L; Feher, M; Forrest, B; Green, E; Hodgson, R; Kiarash, R; Lang, Y; Laufer, R; Leung, G; Li, SW; Liu, Y; Luo, X; Mak, TW; Mao, G; Mason, JM; Pan, G; Pauls, HW; Plotnikova, O; Sampson, P; Wei, X; Yao, Y | 1 |
2 other study(ies) available for go 6976 and axitinib
Article | Year |
---|---|
Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Androstadienes; Binding Sites; Cell Cycle Proteins; Humans; Models, Molecular; Molecular Sequence Data; Peptide Library; Polo-Like Kinase 1; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Substrate Specificity; Wortmannin | 2007 |
The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Indazoles; Indoles; Mice; Mice, SCID; Models, Molecular; Protein Serine-Threonine Kinases; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous | 2013 |